Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
半乳糖凝集素-3：一种早期预测性生物标志物，可用于评估接受奥马珠单抗治疗36个月的重度哮喘患者气道重塑的调节情况。
期刊:Clinical and Translational Allergy
影响因子:4
doi:10.1186/s13601-017-0143-1
Riccio, Anna Maria; Mauri, Pierluigi; De Ferrari, Laura; Rossi, Rossana; Di Silvestre, Dario; Benazzi, Louise; Chiappori, Alessandra; Dal Negro, Roberto Walter; Micheletto, Claudio; Canonica, Giorgio Walter
